Abstract: Provided herein are various embodiments relating to antibodies that bind LILRB2. Anti-LILRB2 antibodies can be used in methods to treat disease, for example, cancer.

Abstract: Provided herein are various embodiments relating to antibodies that bind LILRB2. Anti-LILRB2 antibodies can be used in methods to treat disease, for example, cancer.

Abstract: Provided herein are various embodiments relating to antibodies that bind LILRB2. Anti-LILRB2 antibodies can be used in methods to treat disease, for example, cancer.

Abstract: A method and apparatus is disclosed by which a device in a wireless network may determine and reduce interference when using channels in restricted frequency bands and when other networks may be transmitting in the same restricted frequency. The wireless network may be a Wi-Fi system utilizing channels/frequencies in the television white space. Receivers, such as a client device and access point (AP), may determine information on one or more interfering signals and utilize the information to reduce or cancel the interference caused by the interfering signals generated by a second network. The information may be parameters or information on the structure of the interfering signal, and may be determined by retrieving stored cache information, receiving information on a beacon signal or sampling an interfering signal. The interference cancellation may be performed by joint demodulation or parallel interference cancellation.

Abstract: Provided herein are various embodiments relating to antibodies that bind LILRB2. Anti-LILRB2 antibodies can be used in methods to treat disease, for example, cancer.

Abstract: Provided herein are various embodiments relating to antibodies that bind LILRB2. Anti-LILRB2 antibodies can be used in methods to treat disease, for example, cancer.

Abstract: Provided herein are various embodiments relating to antibodies that bind LILRB2. Anti-LILRB2 antibodies can be used in methods to treat disease, for example, cancer.

Abstract: Provided herein are various embodiments relating to antibodies that bind LILRB2. Anti-LILRB2 antibodies can be used in methods to treat disease, for example, cancer.

Abstract: A method and apparatus is disclosed by which a device in a wireless network may determine and reduce interference when using channels in restricted frequency bands and when other networks may be transmitting in the same restricted frequency. The wireless network may be a Wi-Fi system utilizing channels/frequencies in the television white space. Receivers, such as a client device and access point (AP), may determine information on one or more interfering signals and utilize the information to reduce or cancel the interference caused by the interfering signals generated by a second network. The information may be parameters or information on the structure of the interfering signal, and may be determined by retrieving stored cache information, receiving information on a beacon signal or sampling an interfering signal. The interference cancellation may be performed by joint demodulation or parallel interference cancellation.

Abstract: Devices for labeling and discharging a contaminated fluid, and discharging a contaminant to prevent a contaminated fluid from being used. In an embodiment, a discharging device includes a wax sealing an aperture at the bottom of a water bottle. The wax melts at a high temperature which may cause the water in the bottle contaminated, releasing the water from the water bottle. In another embodiment, a discharging device including an aperture in a DEF tank and a seal material sealing the aperture is used to discharge mistakenly filled contaminant, which dissolves the seal material. In another embodiment, a labeling device including an ink sealed in a wax wrapper is disclosed. The wax wrapper melts at high temperature, releasing the ink and labeling a fluid as problematic. By using a conductive ink with a non-conductive fluid, the labeling device can also be used for detecting and recording high temperature events.